RESEARCH PAPER
Cognition and status quo of antibiotic use among primary doctors in Sichuan Province, China
Li-hong He* 1  
,   Yu-bao Lu* 2  
,   Shi-min Zheng 2,   Huan Xue 1,   Yue Cheng 2,   Jian-xiao Liu 2,   Dun-han Yao 1,   Ling-yun Wang 1,   Yong-lin He 1
 
More details
Hide details
1
The First Clinical Medical College, Lanzhou University, Lanzhou, China
2
The Second Clinical Medical College, Lanzhou University, Lanzhou, China
CORRESPONDING AUTHOR
Li-hong He*   

The First Clinical Medical College, Lanzhou University, No.222 Tianshui South Street, Lanzhou, Gansu 730000, China
Submission date: 2019-09-13
Final revision date: 2019-10-26
Acceptance date: 2019-10-28
Publication date: 2019-11-12
 
Popul. Med. 2019;1(November):3
 
KEYWORDS
TOPICS
* Contributed equally
ABSTRACT
Introduction:
The aim of this study was to understand the knowledge and current situation of antibiotic use among primary doctors in Sichuan Province, 10 years after the new healthcare reform, to analyze the implementation and impact of the relevant policies of the new healthcare reform, to analyze the reasons for the irrational use of antibiotics, and to provide relevant suggestions for the rational use of antibiotics.

Methods:
From August 2018 to March 2019, five counties (cities) were randomly selected according to the level of urban development and geographical distribution in Sichuan Province, China. Various primary medical institutions and private clinics were randomly selected at different levels. Questionnaires and on-site interviews were conducted to quantitatively analyze doctors’ knowledge of antibiotic use and current situation. Views on antibiotic use were analyzed qualitatively and from multiple perspectives. A total of 492 questionnaires were issued, 430 of which were valid, with an effective recovery rate of 87.4%

Results:
Quantitative analysis showed that 92.1% of 430 doctors surveyed knew the rules and authority of antibiotic use; 83.5% participated in antibiotic knowledge training; 56.7% would abide by guidance on antibiotic use; 72.6% thought that their knowledge of antibiotics needed to be improved. The rank-sum test shows that the cognitive differences of doctors with or without relevant training experience are statistically significant (p=0.018), those with the relevant training were better than the untrained doctors; the cognitive differences of doctors with different working years were statistically significant (p=0.038), and the doctors working under 10 years were better than those with 10–20 years; There was no significant difference in the correct rate of antibiotic use among doctors with different academic qualifications (p=0.077). There was no significant difference in knowing the correct rate of antibiotic use among doctors of different genders (p=0.076).

Conclusions:
Ten years after the introduction of the new healthcare reform policy, the improvement of antibiotic use is still far from the expected goal; the knowledge of antibiotic rational use of doctors in primary medical institutions needs to be strengthened, especially in village clinics and private clinics; joint efforts of doctors, patients and supervisors are needed to promote the rational use of antibiotics.

CONFLICTS OF INTEREST
The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
FUNDING
This study was supported by grants from the Excellence Program Fund of Lanzhou University (No.20180060058).
PROVENANCE AND PEER REVIEW
Not commissioned; externally peer reviewed.
 
REFERENCES (18)
1.
Jones RN. The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years. Infection. 1994;22(Suppl 3):S152-S160.
 
2.
Reynolds L, Mckee M . Factors influencing antibiotic prescribing in China: An exploratory analysis. Health Policy. 2009;90(1):32-36. doi:10.1016/j.healthpol.2008.09.002
 
3.
Dong L, Yan H, Wang D. Drug prescribing indicators in village health clinics across 10 provinces of Western China. Fam Pract. 2011;28(1):63-67. doi:10.1093/fampra/cmq077
 
4.
O'Neill J. Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations. London: HM Goverment; 2014. https://amr-review.org/sites/d.... Accessed September 13, 2019.
 
5.
Li Wenmin, Lu Yaling, Chen Mengyuan, et al. A Meta-analysis of the antibiotic use rate of upper respiratory tract infection in children before and after the new medical reform in China. Chinese Pharmaceutical Journal. 2017;52(10):880-885.
 
6.
Kapoor G, Saigal S, Elongavan A. Action and resistance mechanisms of antibiotics: A guide for clinicians. J Anaesthesiol Clin Pharmacol. 2017;33(3):300-305. doi:10.4103/joacp.joacp_349_15
 
7.
Schuts EC, Hulscher MEJL, Mouton JW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847-856. doi:10.1016/S1473-3099(16)00065-7
 
8.
Cohen R, Grimprel E, Hau I, Madhi F, Gaudelus J, Raymond J. Principles of curative antibiotic treatment. Arch Pediatr. 2017;24(12S):S1-S5. doi:10.1016/S0929-693X(17)30510-9
 
9.
Ministry of Health of the People's Republic of China, State Administration of Traditional Chinese Medicine, General Logistics Department of the People's Liberation Army. Guiding Principles for Clinical Application of Antimicrobial Drugs. Chinese Journal of Practical Rural Doctors. 2005;12(10):1-4.
 
10.
Ruibai Wang, Jing Lou, Jie Liu, et al. Antibiotic resistance of Vibrio cholerae O1 El Tor strains from the seventh pandemic in China, 1961–2010. Int J Antimicrob Agents. 2012;40(4):361-364. doi:10.1016/j.ijantimicag.2012.06.010
 
11.
Shi L. Distribution and characterization of integrons in various serogroups of Vibrio cholerae strains isolated from diarrhoeal patients between 1992 and 2000 in Kolkata, India. Journal of Medical Microbiology. 2006;55(5):575-583. doi:10.1099/jmm.0.46339-0
 
12.
Cooper KLF, Luey CKY, Bird M, et al. Development and Validation of a Pulse Net Standardized Pulsed-Field Gel Electrophoresis Protocol for Subtyping of Vibrio cholerae. Foodborne Pathogens & Disease. 2006;3(1):51-58. doi:10.1089/fpd.2006.3.51
 
13.
Guan X, Tian Y, Song J, Zhu D, Shi L. Effect of physicians' knowledge on antibiotics rational use in China's county hospitals. Soc Sci Med. 2019;224:149-155. doi:10.1016/j.socscimed.2019.01.049
 
14.
Liu C. Global attention: Pay attention to the countermeasures of antibiotic development and drug resistance risk. Chinese Journal of Antibiotics. 2019;1:1-8.
 
15.
McNulty CAM. European Antibiotic Awareness Day 2012: general practitioners encouraged to TARGET antibiotics through guidance, education and tools. Journal of Antimicrobial Chemotherapy. 2012;67(11):2543-2546. doi:10.1093/jac/dks358
 
16.
Zhu L, Lin S, Liu Y. The National Governance Strategy of the United States to Deal with Antibiotic Resistance and Its Enlightenment to China. Chinese Journal of Pharmaceutical Economics. 2018;13(09):119-123.
 
17.
Liu Y, Han M, Pei S, Wu J. Governance framework and action plan for antibiotic resistance in Europe. Chinese Journal of Hospital Pharmacy. 2019;39(3):219-223.
 
18.
Gilchrist M, Wade P, Ashiru-Oredope D, Howard P, Sneddon J, Whitney L, Wickens H. Antimicrobial Stewardship from Policy to Practice: Experiences from UK Antimicrobial Pharmacists. Infect Dis Ther. 2015;4(Suppl 1):51-64. doi:10.1007/s40121-015-0080-z
 
ISSN:2654-1459